Navigation Links
Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Date:2/23/2010

======= ====== Basic shares 62,189 56,430 59,215 55,915 Dilutive effect of options and restricted stock - - 292 850 Dilutive effect of convertible senior notes (3) - - - - ------ ------ ------- ------- Diluted shares 62,189 56,430 59,507 56,765 ======= ======== ======= ====== (3) Under the "if-converted" method, interest and issuance costs and potential common shares related to the Company's convertible senior notes were excluded in the computation of diluted per share amounts for the three months and year ended December 31, 2009 because their effect would be anti-dilutive.
    
    
                        ONYX PHARMACEUTICALS, INC.
             CALCULATION OF REVENUE FROM COLLABORATION AGREEMENT
                       (In thousands, unaudited)
                                             
                                       Three Months           Year 
                                          Ended               Ended
                                       December 31,        December 31,
                                     -----------------   -----------------
                                      2009       2008     2009       2008  
                                     ------     ------   ------     ------
    Nexavar product revenue,
     net (as recorded by Bayer)     $235,175  $176,503  $843,470  $677,806
                                    ========  ========  ========  ========
    Revenue subject to
     profit sharing (as recorded
     by Bayer)                      $205,247  $160,874  $753,340  $637,459
    Combined cost of goods sold,
     distribution, selling,
 
'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
2. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
3. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
5. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
6. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
7. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
10. Transdel Pharmaceuticals Announces Management Reorganization
11. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 DURECT Corporation (Nasdaq: DRRX ... , President and CEO, will be presenting at ... 8 at 11:45 a.m. Eastern Time.  The conference ... in New York City.  Investors and analysts that ... meeting through the conference organizers at http://www.cantorconferences.com/health-registration/health-investors ...
(Date:6/29/2015)... -- According to a new market research report ... Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, ... by MarketsandMarkets, the global Tumor Ablation Market Is Poised to ... 11.5% from 2015 to 2020. Browse 72 ... igures spread through 330 P ages ...
(Date:6/29/2015)... , June 29, 2015 The Parenteral Drug ... New Jersey Board of Professional Engineers and ... of courses to professional engineers for continuing professional competency ... demonstrates the value and quality of PDA,s professional education ... lecture courses and hands-on professional training at the Training ...
Breaking Medicine Technology:DURECT to Present at the Cantor Fitzgerald Healthcare Conference 2Tumor Ablation Market Worth $515.2 Million by 2020 2Tumor Ablation Market Worth $515.2 Million by 2020 3Tumor Ablation Market Worth $515.2 Million by 2020 4
(Date:6/30/2015)... NV (PRWEB) , ... June 30, 2015 , ... ... returned to the U.S. after a 5-day tour in India. During her ... currently collaborating with Trivedi Master Wellness™ and Transformational Leader/Internationally Beloved Spiritual ...
(Date:6/30/2015)... ... , ... Skin Brushing (also known as Body Brushing) is a wonderful daily practice all year ... is more exposed to the elements. , Dry Skin Brushing takes only 10 minutes per ... dead cells and toxins on skin's surface. Skin is the largest organ of elimination and ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... ... announced the general availability of three new apps – AvePoint Watermark, ... Online. With the addition of these apps, workers can better streamline everyday business operations ...
(Date:6/30/2015)... ... 30, 2015 , ... Some may define success as the sum of small ... York State Athletic Trainers’ Association (NYSATA) and its members continue to be acknowledged and ... and a number of members also received honors at the national level. ...
(Date:6/30/2015)... ... June 30, 2015 , ... Intellitec Solutions has announced ... update to Dynamics CRM. With the enhanced changes and new procedures involved with updating ... agenda will feature a look at the new user interface and what it will ...
Breaking Medicine News(10 mins):Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 2Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 3Health News:AvePoint Enhances Workforce Productivity and Document Protection on Microsoft Office 365 with the Release of Three New Apps 4Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:Intellitec Solutions to Host Microsoft CRM 2015 Update Webinar 2
... (HealthDay News) -- An investigational drug called pridopidine seems ... progressive movement disorder Huntington,s disease, researchers report. Huntington,s ... The new drug stabilizes dopamine signaling in areas of ... to the study authors, this is the first drug ...
... TORONTO, Ont., Nov. 7, 2011St. Michael,s Hospital announced ... Grand Challenges Explorations, an initiative created by the ... worldwide to test unorthodox ideas that address persistent ... an infectious disease consultant, will pursue an innovative ...
... HealthDay Reporter , MONDAY, Nov. 7 (HealthDay News) -- ... one of the safest over-the-counter medications. It,s approved for use ... use during pregnancy. But an Ohio pediatrician thinks ... popularly known as Tylenol -- particularly in people with asthma. ...
... records have been going electronic, and patients, caregivers, ... new digital world of health information. Now three ... large populationpeople with disabilitiescan best access this information. ... the Inglis Foundation, also based in Philadelphia, are ...
... The Children,s Hospital of Philadelphia announced today that it ... created by the Bill & Melinda Gates Foundation that ... persistent health and development challenges. Terri ... and Professor of Pediatrics at the Perelman School of ...
... has been awarded to the Scott & White Healthcare Cancer ... investigational drugs for the prevention and treatment of cancer. It ... award from the Cancer Prevention Research Institute of Texas (CPRIT), ... research in the state. The CRI grant is ...
Cached Medicine News:Health News:New Drug Shows Promise Against Huntington's Disease 2Health News:New Drug Shows Promise Against Huntington's Disease 3Health News:St. Michael's Hospital receives Grand Challenges Explorations funding 2Health News:Experts Debate Tylenol's Safety for Asthmatic Kids 2Health News:Experts Debate Tylenol's Safety for Asthmatic Kids 3Health News:Grant will help bridge digital divide for people with disabilities 2Health News:Grant will help bridge digital divide for people with disabilities 3Health News:The Children's Hospital of Philadelphia receives Grand Challenges Explorations funding 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: